The pharmacy residency programs at UT Medical Center in Knoxville, Tennessee, train pharmacists to be skilled practitioners, researchers and educators. The programs are accredited by the American Society of Health-System Pharmacists. The Department of Pharmacy offers both Postgraduate Year One (PGY1) and Post Graduate Year Two (PGY2) pharmacy residency programs. Learn more about our:
To develop pharmacy leaders through a personalized approach within an integrated practice model and collaboration in discovery, education, and patient care.
To be nationally recognized for excellence in patient care, medical education and biomedical research.
The department of pharmacy operates to ensure positive drug therapy outcomes for our patients and contribute to achieving the objectives of the Medical Center by:
Benefits include comprehensive health insurance, annual leave, sick leave, educational leave, travel allowances and other university-related benefits.
Purpose and Competencies
PGY1 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training. They will have demonstrated competency in the following areas:
Description
This program is a one year ASHP-accredited residency designed to allow pharmacists to develop strong foundational pharmacotherapy, operational, and practice management skills enabling them to progress towards personal goals. PGY1 residents will refine these skills via a well-established integrated clinical practice model. Required rotations and experiences include internal medicine, critical care medicine/critical care trauma, ambulatory care, family medicine, practice management, hospital pharmacy practice including cardiac arrest response, drug information/drug policy, and the completion of a research project. Electives include infectious disease, emergency medicine, women and infants medicine, transitional care, oncology, transplant, neurology/neurocritical care, nephrology, cardiology, night-shift medicine, pharmacy informatics, and completion of a teaching and learning program.
Residents are invited to participate in the Mentorship Program in which they are paired with a mentor with similar interests. This program is optional and is intended to assist with both professional and personal growth during the residency year.
For additional information, contact:
PGY1 Pharmacy Residency Program Director
Nikki B. Freeman, PharmD, BCPS
865-305-8349
KNFreeman@utmck.edu
Program Coordinator
Carrie Brusseau, Pharm.D.
865-305-6711
CBrussea@utmck.edu
Purpose and Competencies
PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.
Description
This ambulatory care residency program offers advanced, comprehensive training that provides residents the opportunity to develop competency in various ambulatory care pharmacy practice settings. Residents will have the opportunity to participate in a teaching certificate program, formal lectures, precept students and PGY1 residents, complete a research project, and attend residency conferences. Learning experiences include academia, administration, ambulatory infusion, cardiovascular, emergency medicine, family medicine, gastroenterology, heart failure, hematology/oncology, internal medicine, infectious disease, outcomes research, population health, pulmonary, rheumatology, specialty pharmacy and transplant.
For additional information contact:
PGY2 Ambulatory Care Program Director
Jeff Lewis, PharmD, BCPS, BCACP, CDCES
865-305-2868
JLewis2@utmck.edu
Purpose and Competencies
PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available. They will have achieved advanced competencies in critical care as evidenced by their ability to:
Description
This residency program facilitates the development of critical care pharmacy specialists who excel in providing care to critically ill patients and are qualified for a clinical faculty appointment at a college of pharmacy. Residents will refine their skills in the critical care environment via a well-established integrated clinical practice model with increased autonomy and responsibility for managing patient care, overseeing pharmacy students and residents, and involvement with practice management endeavors. Required learning experiences include trauma I and II, critical care medicine, emergency medicine, metabolic support, neurocritical care, cardiovascular critical care, infectious diseases, and academia. In addition, completion of the teaching and learning program is required if one was not completed during the PGY1 residency year. Elective experiences include neonatology, critical care medicine II, emergency medicine II, nightshift medicine, and transplant medicine.
For additional information, contact:
PGY2 Critical Care Program Director
Amanda McKinney, Pharm.D., BCCCP
865-305-7508
ALMcKinney@utmck.edu
Purpose and Competencies
PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available. The PGY2 Internal Medicine Pharmacy Residency will focus on the following competency areas:
Description
This program is a one year ASHP-accredited residency designed to build on the foundational skills gained during the PGY1 residency year. Completion of an ASHP-accredited PGY1 residency is required. Residents will refine their skills in the internal medicine environment via a well-established integrated clinical practice model with increased autonomy and responsibility for managing patient care practice and overseeing pharmacy students and PGY1 residents. Internal medicine (4 months), critical care medicine, infectious diseases, and one medicine sub-specialty are required month-long experiences. Required longitudinal experiences include ambulatory care, academia, drug policy, clinical leadership, hospital pharmacy practice, and completion of a research project. Elective month-long experiences include academia, ambulatory care, cardiology, cardiovascular critical care, emergency medicine, family medicine, geriatrics, hematology/oncology, informatics, medicine/trauma step-down, nephrology, neurocritical care, neurology, nightshift medicine, pain management, practice management, and transplant.
For additional information, contact:
PGY2 Internal Medicine Program Director
John R. Yates, Pharm.D., BCPS
865-305-3711
JRYates@utmck.edu
Purpose and Competencies
PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.
Description
This oncology pharmacy residency offers advanced, comprehensive training that provides residents the opportunity to develop competency in both inpatient solid and blood tumors, transplantation and cellular therapy, and ambulatory clinics. Residents will have the opportunity to initiate or expand oncology pharmacy services, provide formal lectures, precept students and PGY1 residents, complete a research project, and attend residency conferences. Required learning experiences include 6 outpatient rotations consisting of lung, breast/melanoma, GI malignancies, prostate/renal, gynecologic malignancies, pediatric hematology/oncology, and chronic leukemias/Hodgkin’s lymphoma, and 3 inpatient rotations consisting of Non-Hodgkin’s lymphoma, multiple myeloma/acute myeloid leukemia, and transplantation and cellular therapy. Required longitudinal learning experiences include practice management, ambulatory infusion pharmacy, and investigational drug service. Elective learning experiences include palliative care and infectious disease. Graduates of this program will gain a broad experience-based foundation in hematology/oncology, preparing them to practice independently in a variety of inpatient or ambulatory oncology patient-care settings and to successfully obtain BCOP certification.
For additional information, contact:
PGY2 Oncology Program Director865-305-9124cmallon@utmck.edu
Courtney Mallon, PharmD, BCOPProgram Coordinator865-305-9132hpatel4@utmck.edu
Hima Patel, PharmD, BCOPPurpose and Competencies
Pharmacists completing the 24-month pharmacy residency in pharmacotherapy will be prepared for a career as a clinical pharmacy specialist caring for diverse inpatient and outpatient populations with the ability to qualify for faculty positions at a college of pharmacy. They will have achieved advanced competencies in a variety of patient settings and academia in the following competency areas:
Description
This program is a 24-month residency designed to allow the pharmacist to develop strong foundational pharmacotherapy, operational, practice management, and academic skills enabling them to progress towards personal goals. Residents will practice with an increasing level of autonomy and responsibility for managing patient care practices as well as overseeing pharmacy students and residents as the years progress. Teaching, writing and research skills will be enhanced to prepare for a faculty position. Required components of the program include family medicine, ambulatory care, critical care medicine, transplant medicine, oncology, infectious disease, academia, practice management, drug information/drug use policy, hospital pharmacy practice and the completion of a project. Additional requirements include the completion of a teaching certificate program with opportunities for didactic, small-group and case-based teaching. Multiple inpatient and outpatient opportunities are available as elective experiences.
For additional information, contact:
Pharmacotherapy Program Director
Andrea Franks, Pharm.D., BCPS
865-974-2357
afranks@uthsc.edu
Pharmacotherapy Program Coordinator
Shaunta Chamberlin, Pharm.D., BCPS, FCCP
865-305-5061
schamberlin@utmck.edu
Applications for all pharmacy residency programs will be processed using the PhORCAS residency application system. The application deadline is December 30.
Check out what’s available. https://www.visitknoxville.com/
Follow us on social media. Check out our Instagram page @utmcpharmacyresidency.
Follow us on social media. Check out our Instagram page @utmcpharmacyresidency.